A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus
Authors:
- Seong-Wook ParkSPSeong-Wook Park
- Young-Hak KimYKYoung-Hak Kim
- Sung-Cheol YunSYSung-Cheol Yun
- Duk-Woo ParkDPDuk-Woo Park
- Cheol Whan LeeCLCheol Whan Lee
- Myeong-Ki HongMHMyeong-Ki Hong
- Kyoung-Suk RheeKRKyoung-Suk Rhee
- Jei Keon ChaeJCJei Keon Chae
- Jae-Ki KoJKJae-Ki Ko
- Jae-Hyeong ParkJPJae-Hyeong Park
- Jae-Hwan LeeJLJae-Hwan Lee
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparison of Outcomes Using Sirolimus-Eluting Stenting in Diabetic Versus Nondiabetic Patients With Comparison of Insulin Versus Non–Insulin Therapy in the Diabetic PatientsThe American Journal of Cardiology, 2007
- Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary ArteryThe American Journal of Cardiology, 2006
- Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes MellitusThe American Journal of Cardiology, 2006
- The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitusEuropean Heart Journal, 2006
- Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetesHeart, 2006
- Impact of Diabetes Mellitus on Angiographic and Clinical Outcomes in the Drug-Eluting Stents EraThe American Journal of Cardiology, 2005
- Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic PatientsCirculation, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Increased Restenosis in Diabetes Mellitus After Coronary Interventions Is Due to Exaggerated Intimal HyperplasiaCirculation, 1997
- Coronary Angioplasty in Diabetic PatientsCirculation, 1996